Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 3
1992 2
1995 2
2003 1
2004 2
2005 2
2006 3
2007 2
2008 5
2009 3
2010 2
2011 3
2012 3
2014 5
2015 9
2016 7
2017 14
2018 8
2019 3
2020 4
2021 7
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
[Scleroderma].
Fonollosa Pla V, Simeón Aznar CP. Fonollosa Pla V, et al. Among authors: simeon aznar cp. Med Clin (Barc). 2004 Mar 27;122(11):418-9. doi: 10.1016/s0025-7753(04)74258-x. Med Clin (Barc). 2004. PMID: 15066250 Spanish. No abstract available.
[Raynaud's phenomenon].
Tolosa Vilella C, Simeón Aznar CP, Gabarró Julià L. Tolosa Vilella C, et al. Among authors: simeon aznar cp. Med Clin (Barc). 2009 May 16;132(18):712-8. doi: 10.1016/j.medcli.2008.11.017. Epub 2009 Mar 6. Med Clin (Barc). 2009. PMID: 19268319 Free article. Review. Spanish.
The challenge of comprehensive nailfold videocapillaroscopy practice: a further contribution.
Gracia Tello B, Ramos Ibañez E, Fanlo Mateo P, Sáez Cómet L, Martínez Robles E, Ríos Blanco JJ, Marí Alfonso B, Espinosa Garriga G, Todolí Parra J, Ortego Centeno N, Callejas Rubio JL, Freire Dapena M, Marín Ballvé A, Selva-O'Callaghan A, Guillén Del Castillo A, Simeón Aznar CP, Fonollosa Pla V. Gracia Tello B, et al. Among authors: simeon aznar cp. Clin Exp Rheumatol. 2021 Dec 16. Online ahead of print. Clin Exp Rheumatol. 2021. PMID: 34936544
[Pulmonary hypertension in scleroderma].
Fonollosa-Pla V, Simeón-Aznar CP. Fonollosa-Pla V, et al. Among authors: simeon aznar cp. Med Clin (Barc). 2016 Jan 1;146(1):21-3. doi: 10.1016/j.medcli.2015.07.002. Epub 2015 Sep 3. Med Clin (Barc). 2016. PMID: 26343153 Spanish. No abstract available.
Novel risk factors related to cancer in scleroderma.
Bernal-Bello D, de Tena JG, Guillén-Del Castillo A, Selva-O'Callaghan A, Callejas-Moraga EL, Marín-Sánchez AM, Fonollosa-Pla V, Simeón-Aznar CP. Bernal-Bello D, et al. Among authors: simeon aznar cp. Autoimmun Rev. 2017 May;16(5):461-468. doi: 10.1016/j.autrev.2017.03.012. Epub 2017 Mar 8. Autoimmun Rev. 2017. PMID: 28285170 Review.
Circulating Cell Biomarkers in Pulmonary Arterial Hypertension: Relationship with Clinical Heterogeneity and Therapeutic Response.
Tura-Ceide O, Blanco I, Garcia-Lucio J, Del Pozo R, García AR, Ferrer E, Crespo I, Rodríguez-Chiaradia DA, Simeon-Aznar CP, López-Meseguer M, Martín-Ontiyuelo C, Peinado VI, Barberà JA. Tura-Ceide O, et al. Among authors: simeon aznar cp. Cells. 2021 Jul 4;10(7):1688. doi: 10.3390/cells10071688. Cells. 2021. PMID: 34359858 Free PMC article.
Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis.
Callejas-Moraga EL, Guillén-Del-Castillo A, Perurena-Prieto J, Sanz-Martínez MT, Fonollosa-Pla V, Lorite-Gomez K, Severino A, Bellocchi C, Beretta L, Mahler M, Simeón-Aznar CP. Callejas-Moraga EL, et al. Among authors: simeon aznar cp. Rheumatology (Oxford). 2021 Dec 24;61(1):154-162. doi: 10.1093/rheumatology/keab279. Rheumatology (Oxford). 2021. PMID: 33742673
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.
Acosta-Herrera M, Kerick M, Lopéz-Isac E, Assassi S, Beretta L, Simeón-Aznar CP, Ortego-Centeno N; International SSc Group, Proudman SM; Australian Scleroderma Interest Group (ASIG), Hunzelmann N, Moroncini G, de Vries-Bouwstra JK, Orozco G, Barton A, Herrick AL, Terao C, Allanore Y, Brown MA, Radstake TR, Fonseca C, Denton CP, Mayes MD, Martin J. Acosta-Herrera M, et al. Among authors: simeon aznar cp. Ann Rheum Dis. 2021 Apr 1;80(8):1040-7. doi: 10.1136/annrheumdis-2021-219884. Online ahead of print. Ann Rheum Dis. 2021. PMID: 34096881 Free PMC article.
Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507].
Rubio-Rivas M, Corbella X, Guillén-Del-Castillo A, Tolosa Vilella C, Colunga Argüelles D, Argibay A, Vargas Hitos JA, Todolí Parra JA, González-Echávarri C, Ortego-Centeno N, Trapiella Martínez L, Rodríguez Carballeira M, Marín Ballvé A, Pla Salas X, Perales Fraile I, Chamorro AJ, Madroñero Vuelta AB, Freire M, Ruiz Muñoz M, González García A, Pons Martín Del Campo I, Sánchez García ME, Bernal Bello D, Espinosa G, García Hernández FJ, Sáez Comet L, Ríos Blanco JJ, Fernández de la Puebla Giménez RÁ, Sánchez Trigo S, Fonollosa Pla V, Simeón Aznar CP; RESCLE investigators; Autoimmune Diseases Study Group (GEAS). Rubio-Rivas M, et al. Among authors: simeon aznar cp. Autoimmun Rev. 2021 May;20(5):102793. doi: 10.1016/j.autrev.2021.102793. Epub 2021 Mar 22. Autoimmun Rev. 2021. PMID: 33766615 No abstract available.
75 results